394 related articles for article (PubMed ID: 8505546)
1. Rapid generation of monoclonal antibody-secreting hybridomas against African horse sickness virus by in vitro immunization and the fusion/cloning technique.
Stäuber N; Kihm U; McCullough KC
J Immunol Methods; 1993 May; 161(2):157-68. PubMed ID: 8505546
[TBL] [Abstract][Full Text] [Related]
2. Influence of antigen presentation and exogenous cytokine activity during in vitro primary immunizations employed for the generation of monoclonal antibodies.
Halabi G; McCullough KC
J Immunol Methods; 1995 Oct; 186(2):205-16. PubMed ID: 7594620
[TBL] [Abstract][Full Text] [Related]
3. Production of monoclonal antibodies specific for African swine fever virus following in vitro primary immunization of mouse splenocytes in the presence of stimulated T lymphocyte supernatants.
Federspiel G; McCullough KC; Kihm U
J Immunol Methods; 1991 Dec; 145(1-2):71-81. PubMed ID: 1765668
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic methods for African horsesickness virus using monoclonal antibodies to structural and non-structural proteins.
Ranz AI; Miguet JG; Anaya C; Venteo A; Cortés E; Vela C; Sanz A
Vet Microbiol; 1992 Nov; 33(1-4):143-53. PubMed ID: 1481354
[TBL] [Abstract][Full Text] [Related]
5. Production of monoclonal antibodies against the Pasteur (P.V.) strain of rabies virus: problems and results.
Libeau G; Lafon M
Dev Biol Stand; 1984; 57():213-8. PubMed ID: 6526139
[TBL] [Abstract][Full Text] [Related]
6. The use of African horse sickness virus VP7 antigen, synthesised in bacteria, and anti-VP7 monoclonal antibodies in a competitive ELISA.
Wade-Evans AM; Woolhouse T; O'Hara R; Hamblin C
J Virol Methods; 1993 Dec; 45(2):179-88. PubMed ID: 8113344
[TBL] [Abstract][Full Text] [Related]
7. Preparation of recombinant African horse sickness virus VP7 antigen via a simple method and validation of a VP7-based indirect ELISA for the detection of group-specific IgG antibodies in horse sera.
Maree S; Paweska JT
J Virol Methods; 2005 Apr; 125(1):55-65. PubMed ID: 15737417
[TBL] [Abstract][Full Text] [Related]
8. Vaccination with recombinant Modified Vaccinia Ankara (MVA) viruses expressing single African horse sickness virus VP2 antigens induced cross-reactive virus neutralising antibodies (VNAb) in horses when administered in combination.
Manning NM; Bachanek-Bankowska K; Mertens PPC; Castillo-Olivares J
Vaccine; 2017 Oct; 35(44):6024-6029. PubMed ID: 28438410
[TBL] [Abstract][Full Text] [Related]
9. The efficient production of stable, human monoclonal antibody-secreting hybridomas from EBV-transformed lymphocytes using the mouse myeloma X63-Ag8.653 as a fusion partner.
Thompson KM; Hough DW; Maddison PJ; Melamed MD; Hughes-Jones N
J Immunol Methods; 1986 Nov; 94(1-2):7-12. PubMed ID: 3023493
[TBL] [Abstract][Full Text] [Related]
10. Production and properties of monoclonal antibodies against African horsesickness virus, serotype 3.
Van Wyngaardt W; Du Plessis DH; Van Wyngaardt S; Verschoor JA
Onderstepoort J Vet Res; 1992 Jun; 59(2):129-33. PubMed ID: 1513593
[TBL] [Abstract][Full Text] [Related]
11. Antigenic profile of African horse sickness virus serotype 4 VP5 and identification of a neutralizing epitope shared with bluetongue virus and epizootic hemorrhagic disease virus.
Martínez-Torrecuadrada JL; Langeveld JP; Venteo A; Sanz A; Dalsgaard K; Hamilton WD; Meloen RH; Casal JI
Virology; 1999 May; 257(2):449-59. PubMed ID: 10329555
[TBL] [Abstract][Full Text] [Related]
12. The construction and use of a human-mouse myeloma analogue suitable for the routine production of hybridomas secreting human monoclonal antibodies.
Posner MR; Elboim H; Santos D
Hybridoma; 1987 Dec; 6(6):611-25. PubMed ID: 3436625
[TBL] [Abstract][Full Text] [Related]
13. African horsesickness virus VP7 sub-unit vaccine protects mice against a lethal, heterologous serotype challenge.
Wade-Evans AM; Pullen L; Hamblin C; O'Hara R; Burroughs JN; Mertens PP
J Gen Virol; 1997 Jul; 78 ( Pt 7)():1611-6. PubMed ID: 9225037
[TBL] [Abstract][Full Text] [Related]
14. Protective immunization of horses with a recombinant canarypox virus vectored vaccine co-expressing genes encoding the outer capsid proteins of African horse sickness virus.
Guthrie AJ; Quan M; Lourens CW; Audonnet JC; Minke JM; Yao J; He L; Nordgren R; Gardner IA; Maclachlan NJ
Vaccine; 2009 Jul; 27(33):4434-8. PubMed ID: 19490959
[TBL] [Abstract][Full Text] [Related]
15. Preferential generation of monoclonal IgG-producing hybridomas by use of vesicular stomatitis virus-mediated cell fusion.
Nagata S; Yamamoto K; Ueno Y; Kurata T; Chiba J
Hybridoma; 1991 Jun; 10(3):369-78. PubMed ID: 1655635
[TBL] [Abstract][Full Text] [Related]
16. [The isolation and characteristics of hybridomas producing monoclonal antibodies to the structural proteins of the Vnukovo-32 strain of the rabies virus].
Gribencha SV; Vasilenko OV; Furalev VA; Kliushnik SIu; Kuz'mitskaia TM; Sveshinkov PG; Barinskiĭ IF
Vopr Virusol; 1991; 36(4):318-21. PubMed ID: 1796588
[TBL] [Abstract][Full Text] [Related]
17. [Preparation and identification of monoclonal antibodies against African horse sickness virus VP7].
DU F; Feng C; Wang C; Qiu S; Zhang Y; Lin X; Wu S
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Dec; 34(12):1125-1129. PubMed ID: 30626480
[TBL] [Abstract][Full Text] [Related]
18. Identification of a linear neutralization domain in the protein VP2 of African horse sickness virus.
Martínez-Torrecuadrada JL; Casal JI
Virology; 1995 Jul; 210(2):391-9. PubMed ID: 7542417
[TBL] [Abstract][Full Text] [Related]
19. Increased yields of IgG2a- and IgG3-secreting hybridomas after fusion of B cells from mice with autoimmune diseases.
Yin BW; Wong GY; Lloyd KO; Oettgen HF; Welt S
J Immunol Methods; 1991 Nov; 144(2):165-73. PubMed ID: 1960413
[TBL] [Abstract][Full Text] [Related]
20. In vitro immunization for the production of antigen-specific lymphocyte hybridomas.
Borrebaeck CA
Scand J Immunol; 1983 Jul; 18(1):9-12. PubMed ID: 6192490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
